[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO981340L - Stabilized phospholipid compositions - Google Patents

Stabilized phospholipid compositions

Info

Publication number
NO981340L
NO981340L NO981340A NO981340A NO981340L NO 981340 L NO981340 L NO 981340L NO 981340 A NO981340 A NO 981340A NO 981340 A NO981340 A NO 981340A NO 981340 L NO981340 L NO 981340L
Authority
NO
Norway
Prior art keywords
phospholipid compositions
stabilized phospholipid
stabilized
compositions
ammonia
Prior art date
Application number
NO981340A
Other languages
Norwegian (no)
Other versions
NO981340D0 (en
Inventor
Kari Dyvik
Harald Dugstad
Roald Skurtveit
Jo Klaveness
Jonny Istensen
Kiyoto Yachi
Original Assignee
Nycomed Imaging As
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As, Daiichi Seiyaku Co filed Critical Nycomed Imaging As
Publication of NO981340D0 publication Critical patent/NO981340D0/en
Publication of NO981340L publication Critical patent/NO981340L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Stabiliteten til fosfolipidsammensetninger forbedres når det inkluderes et buffersystem som omfatter ammoniakk eller et vannløselig amin med pH 9,5 eller mindre ved 15 °C.The stability of phospholipid compositions is improved when a buffer system comprising ammonia or a water-soluble amine of pH 9.5 or less is included at 15 ° C.

NO981340A 1995-09-27 1998-03-24 Stabilized phospholipid compositions NO981340L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9519654.9A GB9519654D0 (en) 1995-09-27 1995-09-27 Stabilised phospholipid compositions
PCT/GB1996/002364 WO1997011683A2 (en) 1995-09-27 1996-09-25 Stabilised phospholipid compositions

Publications (2)

Publication Number Publication Date
NO981340D0 NO981340D0 (en) 1998-03-24
NO981340L true NO981340L (en) 1998-03-24

Family

ID=10781317

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981340A NO981340L (en) 1995-09-27 1998-03-24 Stabilized phospholipid compositions

Country Status (7)

Country Link
EP (1) EP0857070A2 (en)
JP (1) JP2000515487A (en)
CN (1) CN1202830A (en)
CA (1) CA2233135A1 (en)
GB (1) GB9519654D0 (en)
NO (1) NO981340L (en)
WO (1) WO1997011683A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4752987B2 (en) * 2000-10-12 2011-08-17 ライオン株式会社 External preparation composition
WO2007129311A2 (en) * 2006-05-04 2007-11-15 Pan Sci Tech S.A. Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct
ATE544086T1 (en) * 2007-12-20 2012-02-15 Novartis Ag METHOD FOR PRODUCING CONTACT LENSES
JP5299449B2 (en) * 2011-02-23 2013-09-25 ライオン株式会社 External preparation composition
CN104561156B (en) * 2013-10-28 2020-07-07 丰益(上海)生物技术研发中心有限公司 Process for preparing saturated phospholipids
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof
WO2024199424A1 (en) * 2023-03-30 2024-10-03 上海济煜医药科技有限公司 Phospholipid composition, preparation method therefor and use of nitrogen-containing compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US4962022A (en) * 1986-09-22 1990-10-09 Becton Dickinson And Company Storage and use of liposomes
ZA902710B (en) * 1989-05-22 1991-12-24 Univ Georgia Res Found Enzyme luminescence assay
DE69527194T2 (en) * 1994-03-28 2003-02-06 Daiichi Pharmaceutical Co., Ltd. LIPOSOME CONTAINING AN X-RAY OR ULTRASONIC CONTRAST

Also Published As

Publication number Publication date
CA2233135A1 (en) 1997-04-03
CN1202830A (en) 1998-12-23
WO1997011683A3 (en) 1997-06-26
WO1997011683A2 (en) 1997-04-03
NO981340D0 (en) 1998-03-24
GB9519654D0 (en) 1995-11-29
JP2000515487A (en) 2000-11-21
EP0857070A2 (en) 1998-08-12

Similar Documents

Publication Publication Date Title
RS49673B (en) Nitric oxide synthase inhibitors
AU2733997A (en) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
ES2195970T3 (en) L-RIBAVIRINA AND USES OF THE SAME.
DE3378052D1 (en) Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
BR9909242A (en) A2 phospholipase inhibitors
EP0931788A3 (en) Metalloprotease inhibitors
DE60009511D1 (en) NEMATICIDAL TRIFLUORBUTENE
DK0861228T3 (en) Lipopolyamines as transfection agents as well as their pharmaceutical uses
TR199700660T1 (en) New farnesyl transferase inhibitors.
BR0108871A (en) Compound, compound preparation process and pharmaceutical composition
DK0850221T3 (en) Meta-guanidine, urea, thiourea or azacyclic aminobenzoic acid derivatives as intergrin antagonists
TR199800011T1 (en) Benzo$g] quinoline t�revleri
JO2034B1 (en) LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
BR9909819A (en) Amide, use of amides, and, pharmaceutical preparation for oral, parenteral or intraperitoneal use
NO954768L (en) N-alkylthiopolyamine derivatives as radioprotective agents
IT1293778B1 (en) 1,4,7,10-TETRAAZABICICLO (8.2.2.)TETRADECAN-2 ONE, ITS PREPARATION AND USE FOR THE PREPARATION OF TETRAAZAMACROCYCLES
TR200000586T2 (en) A method, compositions and kits for enhancing the oral biological usefulness of pharmaceuticals.
BR0016952A (en) Substituted phenyl-piperazine-derived compounds, pharmaceutical composition, use and method
NO981340L (en) Stabilized phospholipid compositions
BR9807471A (en) Use of anti-cd40l compound
BR9709393A (en) Derivatives of n-bis or n-tris - [(1,2-dicarboxyethoxy) ethyl] amine and preparation and use thereof
DK0921793T3 (en) Solid, non-flowing sodium valproate formulations
TR199701202T1 (en) New hydroxymic acid derivatives.
TR199701298T1 (en) Tetralins.
RS49929B (en) A reference compound for use in the analysis of levosimendan batches

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application